COMMAND

New and better treatments for mesothelioma, a lethal cancer caused by asbestos, continue to be the focus of research in the medical science community.  In  my previous post,  I discussed a new mesothelioma treatment successfully proven in preliminary laboratory studies to deliver meso-fighting chemotherapy medication to where it’s needed without destroying healthy cells. Today I’ve got good news on the medication front. Verastem, a pharmaceutical company headquartered in Cambridge, Massachussetts also the home of Harvard University, is planning a sophisticated study to test a new drug aimed … [Read more...]